胡平

文章来源:国际学院 发布时间:2024-06-04 点击数:158 字体:

个人简介


姓名:胡平

性别:男

职称:副教授

学历学位:博士

毕业院校:曼彻斯特大学

授课课程:生物药剂学与药物动力学(全英)、药剂学(全英)

研究领域:

(1)复杂缓控释制剂的设计及评价

(2)炎症和创伤相关的智能响应型小分子及递药系统设计


近五年成果


主要获奖情况:

(1)玛丽居里学者奖学金(2011-2013)

(2)英国海外留学生奖学金(2007-2011)

代表性科研项目:

(1)国家自然科学基金面上项目(82071367),新型H2S供体HSD-B对脑卒中后缺血再灌注损伤的神经保护作用及机制研究(2021-2024),主持

(2)广东省基础与应用基础研究基金项目,(2021A1515220047),基于鼻脑通路的精准药物递送治疗脑卒中及神经修复机制研究(2021-2024),主持

(3)暨南大学引进人才启动项目(2019-2025),主持

代表性论文和专著:

1. Y Chen; Q He; H Lu; J Yang; J Han; Y Zhu; P Hu*, Visualization and correlation of drug release of risperidone/clozapine microspheres in vitro and in vivo based on FRET mechanism, International Journal of Pharmaceutics, 2024, 653, 123885.

2. H Lu, Y Chen, P Hu*, Current Status and Future Prospects of Hydrogen Sulfide donor-Based Delivery Systems, Advanced Therapeutics 2023, 6, 220349.

3. Z Zhou, X Zhang, L Xu, H Lu, Y Chen, C Wu, P Hu*, A self-healing hydrogel based on crosslinked hyaluronic acid and chitosan to facilitate diabetic wound healing, International Journal of Biological Macromolecules 2022, 220, 326-336.

4. L Xu, Z Zhou, Y Chen, H Lu, P Hu*, Resina Draconis Particles Encapsulated in a Hyaluronic-Acid-Based Hydrogel to Treat Complex Burn Wounds, Pharmaceutics 2022, 14 (10), 2087.

5. Mengyun Yao, Yifei Lu, Lin Shi, Yong Huang, Qing Zhang, Jianglin Tan, Ping Hu*, Jianxiang Zhang*, Gaoxing Luo*, Ning Zhang*, A ROS-responsive, self-immolative and self-reporting hydrogen sulphide donor with multiple biological activities for the treatment of myocardial infarction. Bioactive Materials 2022, https://doi.org/10.1016/j.bioactmat.2021.07.011

6. Zhang, N#.; Hu, P.#; Wang, Y.; Tang, Q.;  Zheng, Q.;  Wang, Z.; He, Y.*, A reactive oxygen species (ROS) activated hydrogen sulfide (H2S) donor with self-reporting fluorescence. ACS sensors 2020, 5, 319-326.

7. Zhang, N.;  He, Y.;  Tang, Q.;  Wang, Y.;  Zheng, Q.; Hu, P.*, A mitochondrial targeting two-channel responsive fluorescence probe for imaging the superoxide radical anion in vitro and in vivo. Talanta 2019, 194, 79-85.

代表性专利:

(1)一种阿普斯特缓释植入剂及其制备方法。胡平,王英,黄诗贵,余灏,贺耘(已授权,专利号:ZL201510957710.8)

(2)一种杂原子取代的吡咯烷衍生物的不对称合成方法。邵攀霖,王志鹏,胡平,贺耘(已授权,专利号:CN108658825B)